Image Credit:Ann Mil Health Sci Res
Outline
Side Effects of Sustained-Release Vaginal Suppository Progesterone in Pregnant Women: Gestational Diabetes Mellitus
Authors
Abstract
Background: Evaluation of the potential impact of vaginal progesterone on both mother and fetus is necessary before expanding the indication of this drug especially throughout pregnancy. To evaluate the potential impact of vaginal progesterone on both mother and fetus. Materials and Methods: This case-control study was designed to collect data on the potential gestational diabetes mellitus complication associated with progesterone use comparing maternal and neonatal outcomes between 245pregnant women receiving vaginal suppository of Cyclogest (200mg) and 808controls without progesterone. Results: The incidence of gestational diabetes was 9.8% and 5.2% in case and control groups, respectively (p=0.039). According to linear regression analysis, there was a direct association between duration of progesterone usage and impairment of glucose tolerance test in group of cases (r=0.43; p=0.002). Conclusions: The use of progesterone for the prevention of recurrent preterm delivery could associate with an increased risk of developing gestational diabetes.
Highlights
References
- 1.References are available in pdf.
Copyright
© 2013, Annals of Military and Health Sciences Research. This open-access article is available under the Creative Commons Attribution-NonCommercial 4.0 (CC BY-NC 4.0) International License (https://creativecommons.org/licenses/by-nc/4.0/), which allows for the copying and redistribution of the material only for noncommercial purposes, provided that the original work is properly cited.
Similar Articles
Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion
Ansari I, Hajiseid Javadi E, Pakniat H, Emami A, Ranjkesh F, et al. Micronized Progesterone or Dydrogesterone? A Comparative Study on the Effects of Two Forms of Progesterone on Pregnancy Outcomes After Threatened Abortion. Iran J Pharm Res. 2023;22(1):e136320. doi: https://doi.org/10.5812/ijpr-136320
Comparative Analysis of Corticosteroid Therapy in Pregnant Women with COVID-19: Evaluating Glycemic Control and Transient Hyperglycemia
Salehi MR, Ghaemi M, Masoumi S, Azadnajafabad S, Norooznezhad AH, et al. Comparative Analysis of Corticosteroid Therapy in Pregnant Women with COVID-19: Evaluating Glycemic Control and Transient Hyperglycemia. Fertil Gynecol Androl. 2023;3(1):e142142. doi: https://doi.org/10.5812/fga-142142
Comparison of Pregnancy Outcomes in Diabetic and Healthy Women
Jafari M, Fattahi H, Sheikhy L, Eskandari S, Mirzaei-Alavijeh M. Comparison of Pregnancy Outcomes in Diabetic and Healthy Women. J Health Rep Technol. 2022;8(3):e119317. doi: https://doi.org/10.5812/jhrt-119317
Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus
Farooq M, Ayaz A, Ali Bahoo L, Ahmad I. Maternal and Neonatal Outcomes in Gestational Diabetes Mellitus. Int J Endocrinol Metab. 2007;5(3):. doi:
The Effect of Vaginal Progesterone in Reducing Preterm Birth in Women with an Increased Uterocervical Angle: A Randomized Controlled Trial
Borna S, Eshraghi N, Hantoushzadeh S, Ghotbizadeh Vahdani F, Panahi Z, et al. The Effect of Vaginal Progesterone in Reducing Preterm Birth in Women with an Increased Uterocervical Angle: A Randomized Controlled Trial. J Nurs Midwifery Sci. 2025;12(4):e160082. doi: https://doi.org/10.5812/jnms-160082
- Scopus by DOI: 0
Last Update: 1 week ago
- Scopus by Title: 0
Last Update: 1 week ago
- Scopus by Title (Ref): 0
Last Update: 1 week ago
- CrossRef: 0
Last Update: 4 hours ago
- OpenAlex: 0
Last Update: 8 hours ago
- OpenCitations: 0
Last Update: 5 days ago